Sparian Biosciences Begins Phase I Trial of Oral Pain Drug SBS-147 Targeting Opioid Alternatives
Sparian Biosciences advances SBS-147 into Phase I trials, aiming to develop a safer, non-opioid oral treatment for acute and chronic pain.
National Institute On Drug Abuse | 11/04/2026 | By News Bureau
NIH Scientists Discover Safer, Highly Potent Opioid with Potential for Pain and Addiction Treatment
A newly discovered opioid compound by NIH researchers shows strong pain relief without typical addiction risks, marking a potential breakthrough in safer pain management therapies.
National Institute On Drug Abuse | 06/04/2026 | By News Bureau | 114
A National Institutes of Health-backed study shows weekly injectable buprenorphine improves opioid abstinence and reduces serious risks compared to sublingual treatment in pregnant women with opioid use disorder.
National Institute On Drug Abuse | 18/03/2026 | By News Bureau | 131
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy